Community Pharmacy, Disease State Management, and Adherence to Medication: A Review

Carol Armour, Lorraine Smith and Ines Krass
Additional contact information
Carol Armour: Faculty of Pharmacy, University of Sydney, Sydney, New South Wales, Australia
Lorraine Smith: Faculty of Pharmacy, University of Sydney, Sydney, New South Wales, Australia
Ines Krass: Faculty of Pharmacy, University of Sydney, Sydney, New South Wales, Australia

Disease Management and Health Outcomes, 2008, vol. 16, issue 4, pages 245-254

Abstract: Community pharmacists are well trained healthcare professionals who are able and willing to implement extended medication services. In the past decade, a plethora of pharmaceutical care and pharmacy-based disease management programs have been developed and trialed for delivery in primary care settings. Since suboptimal medication adherence is a feature of chronic illness, it is important to review the success of disease management interventions targeting adherence. This review focuses on the programs that were developed for asthma, diabetes mellitus, and cardiovascular disease in community pharmacies and that either targeted medication adherence or reported it as an outcome. Studies of community pharmacy-based disease management programs targeting adherence in patients with asthma, diabetes mellitus, and cardiovascular disease have demonstrated positive effects on clinical outcomes other than adherence. A variety of adherence-measuring methods were used in these studies, ranging from patient self-report and qualitative descriptions to electronic recording. In most cases, strategies to improve adherence were part of a complex intervention, and a direct link between the intervention and adherence improvement could not be demonstrated. At this stage, it is not known what type of intervention results in the greatest impact and most sustained improvement in medication adherence. Future studies should provide evidence for the impact of adherence on not only clinical and patient-centered outcomes, but also economic outcomes. Evidence for the sustainability of the outcomes should be a priority for future research. DOI: 10.2165/0115677-200816040-00005

JEL-codes: C D I Z I1 I19 I18 I11 (search for similar items in EconPapers)
Date: 2008
References: Add references at CitEc
Citations Track citations by RSS feed

Downloads: (external link)
http://diseasemanagement.adisonline.com/pt/re/dmo/ ... -200816040-00005.pdf (application/pdf)
http://diseasemanagement.adisonline.com/pt/re/dmo/ ... -200816040-00005.htm (text/html)
Pay per view

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: http://EconPapers.repec.org/RePEc:wkh:dmhout:v:16:y:2008:i:4:p:245-254

Access Statistics for this article

Disease Management and Health Outcomes is edited by Christopher I. Carswell, MSc, MRPharmS

More articles in Disease Management and Health Outcomes from Springer Healthcare | Adis
Series data maintained by Dave Dustin ().